Resources

Your Trust Partner in Ovarian Cancer Preclinical Research

Alfa Cytology delivers one-stop preclinical development services for ovarian cancer research, spanning in vitro drug screening, 3D disease modeling, in vivo efficacy evaluation, and safety assessment. Supported by our specialized platform and tailored strategies, we empower accelerated innovation in therapeutic development and streamline translational research from bench to bedside.

Downloads

About Alfa Cytology

As a committed preclinical research service provider focused on cancer, Alfa Ctytology’s one-stop drug discovery services and a range of technology platforms will address the diverse needs of our clients, guaranteeing innovative and effective research results.

Learn More

One-stop Preclinical Services for Cancer Research

At Alfa Cytology, we offer a comprehensive suite of preclinical services tailored to advance cancer research and drug development. Our one-stop preclinical platform provides end-to-end solutions, from disease modeling and diagnostic development to therapeutic evaluation - all under one roof.

Learn More

Designing Your Preclinical Cancer Modeling Mouse Studies

Alfa Cytology was proud to participate in Cancer R&D 2024, where they presented a session titled "Designing Your Preclinical Cancer Modeling Mouse Studies," showcasing their expertise and innovative approaches in developing and optimizing mouse models for preclinical cancer research.

Learn More

How to Select the Right Service Provider for Cancer Therapy Development

When choosing the right service provider for cancer therapy development, it’s essential to consider factors like experience, expertise, and support. Alfa Cytology is here to guide you through this critical selection process.

Downloads

Important Links

Get In Touch

Alfa Cytology, located in New York, specializes in preclinical research solutions to support ovarian cancer therapy development, offering a streamlined process from target discovery to IND application.